INFLAMMATORY MYOPATHY
Clinical trials for INFLAMMATORY MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY MYOPATHY trials appear
Sign up with your email to follow new studies for INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at lupus and muscle disease
Disease control Not yet recruitingThis early-phase study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) from a donor to target and attack faulty cells in people with severe lupus or inflammatory myopathy that hasn't responded to standard therapies. The main goals …
Matched conditions: INFLAMMATORY MYOPATHY
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 26, 2026 10:15 UTC
-
New drug hope for rare muscle disease
Disease control Not yet recruitingThis study tests a drug called telitacicept for people with inflammatory myopathy, a condition where the immune system attacks muscles. The goal is to see if the drug is safe and can help control the disease. About 30 adults who haven't responded well to standard treatments will …
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated May 26, 2026 08:19 UTC